The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
Abstract
OBJECTIVE: Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities. METHOD: This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide. RESULTS: On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality. CONCLUSIONS: Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiovascular disease emerges as the leading cause of premature mortality in individuals with SMI, as supported by substantial evidence [19–22].”
From A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China (2025) · cites this paper as [21]
In the citing paper
“The same method was used in a study from Sweden that found that persons with schizophrenia died 15 years (men) and 12 years (women) earlier than the general population (Crump et al. 2013).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Crump et al. 2013
In the citing paper
“Evidence as to whether excess mortality is predominantly due to unnatural or natural causes of death remains equivocal.2,7,9,12”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.2,25,26”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“People with schizophrenia and other psychotic disorders die earlier than their peers in the general population, with recent estimates suggesting by around 15–20 years.1–10”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“overall, findings on the association between exposure to antipsychotic medication and natural-cause mortality remain inconsistent.2,48,49”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Over the past decades, consistent evidence has accrued that people with psychotic disorder have higher mortality rates than the general population.1–9”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The unhealthy lifestyle of people with schizophrenia
Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 880
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Research works printed but not linked: 6
- National Board of Health and Welfare, 2011, Causes of Death 2010
- Garrett JM, 1997, Stata Technical Bulletin, 35, 9
- StataCorp, 2010, Stata Statistical Software: Release 11.0
- Ji J, Schizophr Bull
- van de Mheen PJ, 1996, Public Health Rep, 111, 420
- Lahti M, Psychol Med
Cited by
Sorted by citations
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116820 · Cited by 1,175
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., Druss, B., Dudek, K., Freeman, M., Fujii, C., et al. (2017) · World Psychiatry · doi:10.1002/wps.20384 · Cited by 865
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 758
Tiihonen, J., Mittendorfer-Rutz, E., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., Tanskanen, A., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1322 · Cited by 670
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Solmi, M., Seitidis, G., Mavridis, D., Correll, C. U., Dragioti, E., Guimond, S., Tuominen, L. J., Dargél, A., Carvalho, A. F., Fornaro, M., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02138-4 · Cited by 642
Impaired Glucose Homeostasis in First-Episode Schizophrenia
Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3803 · Cited by 475
Taipale, H., Tanskanen, A., Mehtälä, J., Vattulainen, P., Correll, C. U., & Tiihonen, J. (2020) · World Psychiatry · doi:10.1002/wps.20699 · Cited by 415
Comorbidity of Severe Psychotic Disorders With Measures of Substance Use
Hartz, S. M., Pato, C. N., Medeiros, H., Cavazos‐Rehg, P. A., Sobell, J. L., Knowles, J. A., Bierut, L. J., & Pato, M. T. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3726 · Cited by 421
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 293
Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
Taipale, H., Mittendorfer-Rutz, E., Alexanderson, K., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.12.010 · Cited by 262
Smıth, D. J., Langan, J., McLean, G., Guthrie, B., & Mercer, S. W. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002808 · Cited by 254
Severance, E. G., Gressitt, K. L., Stallings, C. R., Origoni, A. E., Khushalani, S., Leweke, F. M., Dickerson, F. B., & Yolken, R. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.018 · Cited by 243
Chan, J. K. N., Correll, C. U., Wong, C. S. M., Chu, R. S. T., Fung, V. S. C., Wong, G. H. S., Lei, J. H. C., & Chang, W. C. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102294 · Cited by 284
Sundquist, J., Ohlsson, H., Sundquist, K., & Kendler, K. S. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1381-4 · Cited by 235
Self-citationPillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230
Koutsouleris, N., Kahn, R. S., Chekroud, A. M., Leucht, S., Falkai, P., Wobrock, T., Derks, E. M., Fleischhacker, W., & Hasan, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30171-7 · Cited by 217
Antipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Tiihonen, J., Mittendorfer‐Rutz, E., Torniainen‐Holm, M., Alexanderson, K. A. E., & Tanskanen, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050618 · Cited by 204
Osborn, D. P. J., Hardoon, S., Omar, R. Z., Holt, R. I. G., King, M., Larsen, J., Marston, L., Morris, R. W., Nazareth, I., Walters, K., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2133 · Cited by 200
Catalá-López, F., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Valderas, J. M., Gómez-Beneyto, M., Martı́nez, S., Balanzá‐Martínez, V., Climent, J., Valencia, A., McGrath, J. J., et al. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000356498 · Cited by 203
Cancer care for individuals with schizophrenia
Irwin, K. E., Henderson, D. C., Knight, H. P., & Pirl, W. F. (2013) · Cancer · doi:10.1002/cncr.28431 · Cited by 191
Charlson, F., Baxter, A. J., Dua, T., Degenhardt, L. J., Whiteford, H., & Vos, T. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000687 · Cited by 194
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
Pillinger, T., Beck, K., Stubbs, B., & Howes, O. D. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.200907 · Cited by 177
Clozapine as a Model for Antipsychotic Development
Nucifora, F. C., Mihaljevic, M. M., Lee, B. J., & Sawa, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0552-9 · Cited by 182
Stroup, T. S., Gerhard, T., Crystal, S., Huang, C., & Olfson, M. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030332 · Cited by 179
Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark
Meier, S. M., Mattheisen, M., Mors, O. N., Schendel, D., Mortensen, P. B., & Plessen, K. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3105 · Cited by 179
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Westman, J., Eriksson, S. V., Gissler, M., Hällgren, J., Prieto, M. L., Bobo, W. V., Frye, M. A., Erlinge, D., Alfredsson, L. S., & Ösby, U. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000166 · Cited by 171
Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu138 · Cited by 156
Trachsel, M., Irwin, S. A., Biller-Andorno, N., Hoff, P., & Riese, F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0970-y · Cited by 148
Solmi, M., Fiedorowicz, J. G., Poddighe, L., Delogu, M., Miola, A., Høye, A., Heiberg, I. H., Stubbs, B., Smith, L., Larsson, H., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21010031 · Cited by 153
Smith, D. J., Martin, D., McLean, G., Langan, J., Guthrie, B., & Mercer, S. W. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-263 · Cited by 138
Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease
Hering, D., Lachowska, K., & Schlaich, M. P. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0594-5 · Cited by 142
Schoepf, D., Uppal, H., Potluri, R., & Heun, R. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0436-x · Cited by 134
Social Disconnection in Schizophrenia and the General Community
Green, M. F., Horan, W. P., Lee, J., McCleery, A., Reddy, L. F., & Wynn, J. K. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx082 · Cited by 141
Dragioti, E., Radua, J., Solmi, M., Gosling, C. J., Oliver, D., Lascialfari, F., Ahmed, M., Cortese, S., Estradé, A., Arrondo, G., et al. (2023) · World Psychiatry · doi:10.1002/wps.21068 · Cited by 130
Hayes, R. D., Downs, J. M., Chang, C., Jackson, R., Shetty, H., Broadbent, M., Hotopf, M. H., & Stewart, R. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu120 · Cited by 130
Lambert, A., Parretti, H. M., Pearce, E., Price, M. J., Riley, M. R., Ryan, R. P., Tyldesley‐Marshall, N., Avşar, T. S., Matthewman, G., Lee, A., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003960 · Cited by 135
Stafford, J., Chung, W. T., Sommerlad, A., Kirkbride, J. B., & Howard, R. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5711 · Cited by 126
Fiorillo, A., & Sartorius, N. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00374-y · Cited by 117
Crockford, D. N., & Addington, D. E. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720196 · Cited by 113
Ten-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study
Revier, C. J., Reininghaus, U., Dutta, R., Fearon, P., Murray, R. M., Doody, G. A., Croudace, T. J., Dazzan, P., Heslin, M., Onyejiaka, A. N., et al. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000295 · Cited by 118
Cancer screening, prevention, and treatment in people with mental illness
Weinstein, L. C., Stefančić, A., Cunningham, A., Hurley, K. E., Cabassa, L. J., & Wender, R. C. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21334 · Cited by 112
Excess medical comorbidity and mortality across the lifespan in schizophrenia.
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.020 · Cited by 103
Mortality in Schizophrenia-Spectrum Disorders: Recent Advances in Understanding and Management
Peritogiannis, V., Ninou, A., & Samakouri, M. A. (2022) · Healthcare · doi:10.3390/healthcare10122366 · Cited by 104
Moore, S., Shiers, D., Daly, B., Mitchell, A. J., & Gaughran, F. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12431 · Cited by 107
Kilbourne, A. M., Abraham, K. M., Goodrich, D. E., Bowersox, N. W., Almirall, D., Lai, Z., & Nord, K. M. (2013) · Implementation Science · doi:10.1186/1748-5908-8-136 · Cited by 102
Ayerbe, L., Forgnone, I., Addo, J., Siguero, A., Gelati, S., & Ayis, S. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.002 · Cited by 106
Bitan, D. T., Krieger, I., Kridin, K., Komantscher, D., Scheinman, Y., Weinstein, O., Cohen, A. D., Cicurel, A., & Feingold, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab012 · Cited by 99
Mortality and Medical Comorbidity in the Severely Mentally Ill
Schneider, F. W., Erhart, M., Hewer, W., Loeffler, L. A. K., & Jacobi, F. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0405 · Cited by 95
Cancer mortality in patients with schizophrenia: systematic review and meta-analysis
Zhuo, C., Tao, R., Jiang, R., Lin, X., & Shao, M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195776 · Cited by 93
Excess mortality in severe mental disorders: A systematic review and meta-regression
Ali, S., Santomauro, D. F., Ferrari, A. J., & Charlson, F. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.036 · Cited by 106
Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer
Irwin, K. E., Park, E. R., Fields, L. E., Corveleyn, A. E., Greer, J. A., Perez, G. K., Callaway, C. A., Jacobs, J. M., Nierenberg, A. A., Temel, J. S., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0488 · Cited by 92
Lung function and respiratory diseases in people with psychosis: Population-based study
Partti, K., Vasankari, T., Kanervisto, M., Perälä, J., Saarni, S. I., Jousilahti, P., Lönnqvist, J. K., & Suvisaari, J. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.141937 · Cited by 93
Genetic correlation between smoking behaviors and schizophrenia
Hartz, S. M., Horton, A. C., Hancock, D. B., Baker, T. B., Caporaso, N. E., Chen, L., Hokanson, J. E., Lutz, S. M., Marazita, M. L., McNeil, D. W., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.022 · Cited by 89
Is It Possible to Predict the Future in First-Episode Psychosis?
Suvisaari, J., Mantere, O., Keinänen, J., Mäntylä, T. J. S., Rikandi, E., Lindgren, M., Kieseppä, T., & Raij, T. T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00580 · Cited by 96
Mental Disorders Across the Adult Life Course and Future Coronary Heart Disease
Galé, C. R., Batty, G. D., Osborn, D., Tynelius, P., & Rasmussen, F. E. (2013) · Circulation · doi:10.1161/circulationaha.113.002065 · Cited by 85
Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Mizuki, Y., Sakamoto, S., Okahisa, Y., Yada, Y., Hashimoto, N., Takaki, M., & Yamada, N. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa097 · Cited by 84
Schneider‐Thoma, J., Efthimiou, O., Huhn, M., Krause, M., Reichelt, L., Röder, H., Davis, J. M., Salanti, G., & Leucht, S. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30177-9 · Cited by 83
Heiberg, I. H., Jacobsen, B. K., Balteskard, L., Bramness, J. G., Næss, Ø., Ystrøm, E., Reichborn‐Kjennerud, T., Hultman, C. M., Nesvåg, R., & Høye, A. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13017 · Cited by 85
Morbidity and mortality in schizophrenia with comorbid substance use disorders
Lähteenvuo, M., Batalla, A., Luykx, J. J., Mittendorfer‐Rutz, E., Tanskanen, A. J., Tiihonen, J., & Taipale, H. T. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13291 · Cited by 78
Bitter, I., Czobor, P., Borsi, A., Fehér, L., Nagy, B., Bacskai, M., Rakonczai, P., Hegyi, R., Németh, T., Varga, P., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.05.022 · Cited by 84
Laursen, T. M., Mortensen, P. B., MacCabe, J. H., Cohen, D., & Gasse, C. (2013) · Psychological Medicine · doi:10.1017/s003329171300216x · Cited by 78
Baxter, A. J., Harris, M., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163170 · Cited by 82
Kugathasan, P., Stubbs, B., Aagaard, J., Jensen, S. E., Laursen, T. M., & Nielsen, R. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13076 · Cited by 75
Sandström, Y. K., Ljunggren, G., Wändell, P. E., Wahlström, L., & Carlsson, A. C. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000824 · Cited by 80
Exercise Treatments for Psychosis: a Review
Mittal, V. A., Vargas, T., Osborne, K. J., Dean, D. J., Gupta, T., Ristanovic, I., Hooker, C. I., & Shankman, S. A. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0112-2 · Cited by 86
Cardiovascular effects of psychotic illnesses and antipsychotic therapy
Howell, S., Yarovova, E., Khwanda, A., & Rosen, S. D. (2019) · Heart · doi:10.1136/heartjnl-2017-312107 · Cited by 74
Launders, N., Hayes, J., Price, G., & Osborn, D. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003976 · Cited by 75
Ilyas, A., Chesney, E., & Patel, R. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.203240 · Cited by 76
Ni, L., Wu, J., Long, Y., Tao, J., Xu, J., Yuan, X., Yu, N. H., Wu, R., & Zhang, Y. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2332-z · Cited by 70
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review
Arroll, M. A., Wilder, L., & James, N. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-91 · Cited by 70
Barriers, Benefits, and Strategies for Physical Activity in Patients With Schizophrenia
Rastad, C., Martin, C., & Åsenlöf, P. (2014) · Physical Therapy · doi:10.2522/ptj.20120443 · Cited by 82
Chouinard, V., Pingali, S. M., Chouinard, G., Henderson, D. C., Mallya, S. G., Cypess, A. M., Cohen, B. M., & Öngür, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.024 · Cited by 64
Yung, N. C. L., Wong, C. S. M., Chan, J. K. N., Chen, E. Y. H., & Chang, W. C. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa137 · Cited by 64
Retinal correlates of psychiatric disorders
Almonte, M. T., Capellàn, P., Yap, T. E., & Cordeiro, M. F. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320905215 · Cited by 64
Severe mental illness is associated with increased mortality and severe course of COVID‐19
Barcella, C. A., Polcwiartek, C., Mohr, G. H., Hodges, G. W., Søndergaard, K. B., Bang, C. N., Andersen, M. P., Fosbøl, E. L., Køber, L., Schou, M., et al. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13309 · Cited by 61
Impact of socioeconomic deprivation on rate and cause of death in severe mental illness
Martin, J. L., McLean, G., Park, J. B., Martin, D. J., Connolly, M., Mercer, S. W., & Smıth, D. J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0261-4 · Cited by 62
Klaassen, Z. W. A., Wallis, C. J. D., Goldberg, H., Chandrasekar, T., Sayyid, R. K., Williams, S. B., Moses, K. A., Terris, M. K., Nam, R. K., Urbach, D. R., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0390-0 · Cited by 61
Natural cause mortality in persons with serious mental illness
Dickerson, F., Origoni, A. E., Schroeder, J., Adamos, M. B., Katsafanas, E., Khushalani, S., Savage, C. L. G., Schweinfurth, L. A. B., Stallings, C. R., Sweeney, K., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12880 · Cited by 58
Lamont, E., Harris, J. P., McDonald, G., Kerin, T., & Dickens, G. L. (2017) · Mental health and physical activity · doi:10.1016/j.mhpa.2017.03.003 · Cited by 61
Charlson, F., Baxter, A. J., Dua, T., Degenhardt, L. J., Whiteford, H., & Vos, T. (2016) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0426-7_ch3 · Cited by 55
Stafford, J., Dykxhoorn, J. L., Sommerlad, A., Dalman, C., Kirkbride, J. B., & Howard, R. J. (2021) · Psychological Medicine · doi:10.1017/s0033291721002099 · Cited by 57
Schizophrenia and risk of stroke: a meta-analysis of cohort studies.
Li, M., Fan, Y., Tang, Z.-Y., & Cheng, X.-S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.101 · Cited by 58
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
Madireddy, S., & Madireddy, S. (2020) · Brain Sciences · doi:10.3390/brainsci10100742 · Cited by 56
Woodhead, C., Ashworth, M. J., Broadbent, M. T. M., Callard, F. J., Hotopf, M. H., Schofield, P., Soncul, M., Stewart, R. J., & Henderson, M. J. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x685189 · Cited by 54
Meier, M. H., Gillespie, N. A., Hansell, N. K., Hewitt, A. W., Hickie, I. B., Lu, Y., McGrath, J. J., MacGregor, S., Medland, S. E., Sun, C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.045 · Cited by 56
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156265 · Cited by 53
Pettersson, D. R., Gissler, M., Hällgren, J., Ösby, U., Westman, J., & Bobo, W. V. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602000044x · Cited by 52
Mortality in schizophrenia: clinical and serological predictors
Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt113 · Cited by 50
Gabilondo, A., Alonso-Morán, E., Nuño-Solínis, R., Orueta, J. F., & Iruín, Á. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.12.011 · Cited by 53
Kilbourne, A. M., Almirall, D., Goodrich, D. E., Lai, Z., Abraham, K. M., Nord, K. M., & Bowersox, N. W. (2014) · Implementation Science · doi:10.1186/s13012-014-0163-3 · Cited by 50
Benros, M. E., & Mortensen, P. B. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_93 · Cited by 53
Woodhead, C., Ashworth, M. J., Schofield, P., & Henderson, M. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-117 · Cited by 49
Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom
Iwagami, M., Mansfield, K. E., Hayes, J., Walters, K. R., Osborn, D., Smeeth, L. L., Nitsch, D., & Tomlinson, L. A. (2018) · Clinical Epidemiology · doi:10.2147/clep.s154841 · Cited by 48
Metadata
- Authors
- Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J.
- Affiliations
- Lund University (SE)
- Venue
- American Journal of Psychiatry
- Published
- 2013-03
- Volume
- 170
- Issue
- 3
- Pages
- 324-333
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2157959378
- Cited by
- 619
- References
- 50
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 49 · 2023: 58 · 2022: 47 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 40 · 2017: 59 · 2016: 40 · 2015: 39 · 2014: 46 · 2013: 20
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institute on Drug Abuse (R01DA030005)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, premature mortality, comorbidities, ischemic heart disease, cancer, sex differences, employment status, antipsychotic drugs, underdiagnosis, cardiovascular screening, cancer screening, primary care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Cause of Death, Female, Hospitalization, Humans, Life Expectancy, Male, Middle Aged, Neoplasms, Risk, Schizophrenia, Sweden, Cohort Studies, Comorbidity, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
